An updated patent review of VEGFR-2 inhibitors (2017-present)
Sign Up to like & getrecommendations! Published in 2021 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2021.1935872
Abstract: ABSTRACT Introduction: Angiogenesis is a vital process for cellular functions in both physiological and pathophysiological conditions and is one of the hallmarks of cancer progression and metastasis. VEGF/VEGFR-2 signaling pathway has been recognized as the… read more here.
Keywords: patent review; review vegfr; updated patent; vegfr inhibitors ... See more keywords